Clinical Trial Update: Low Dose Naltrexone Use in Patients With POTS [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the use of low-dose naltrexone in patients with Postural Orthostatic Tachycardia Syndrome, sponsored by the University o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postural Orthostatic Tachycardia Syndrome

Drugs mentioned

• Low Dose Naltrexone (naltrexone)

Snippet

Sponsor: University of Calgary | Conditions: Postural Orthostatic Tachycardia Syndrome | Phase 4 | Status: NOT_YET_RECRUITING